These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22944598)

  • 1. Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers.
    Sousa JF; Ham AJ; Whitwell C; Nam KT; Lee HJ; Yang HK; Kim WH; Zhang B; Li M; LaFleur B; Liebler DC; Goldenring JR
    Am J Pathol; 2012 Nov; 181(5):1560-72. PubMed ID: 22944598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach.
    Sousa JF; Nam KT; Petersen CP; Lee HJ; Yang HK; Kim WH; Goldenring JR
    Gut; 2016 Jun; 65(6):914-24. PubMed ID: 25800782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
    Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
    Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium.
    Taupin D; Pedersen J; Familari M; Cook G; Yeomans N; Giraud AS
    Lab Invest; 2001 Mar; 81(3):397-408. PubMed ID: 11310832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.
    Lee HJ; Nam KT; Park HS; Kim MA; Lafleur BJ; Aburatani H; Yang HK; Kim WH; Goldenring JR
    Gastroenterology; 2010 Jul; 139(1):213-25.e3. PubMed ID: 20398667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
    Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
    Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
    Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
    J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
    Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
    Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.
    Weis VG; Petersen CP; Mills JC; Tuma PL; Whitehead RH; Goldenring JR
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G777-92. PubMed ID: 25190476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
    Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
    Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
    Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
    Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer.
    Goldenring JR; Nam KT; Wang TC; Mills JC; Wright NA
    Gastroenterology; 2010 Jun; 138(7):2207-10, 2210.e1. PubMed ID: 20450866
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
    Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
    Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia.
    Wada T; Ishimoto T; Seishima R; Tsuchihashi K; Yoshikawa M; Oshima H; Oshima M; Masuko T; Wright NA; Furuhashi S; Hirashima K; Baba H; Kitagawa Y; Saya H; Nagano O
    Cancer Sci; 2013 Oct; 104(10):1323-9. PubMed ID: 23848514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.
    Radyk MD; Burclaff J; Willet SG; Mills JC
    Gastroenterology; 2018 Mar; 154(4):839-843.e2. PubMed ID: 29248442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metaplasia in the Stomach-Precursor of Gastric Cancer?
    Kinoshita H; Hayakawa Y; Koike K
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28953255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric de novo Muc13 expression and spasmolytic polypeptide-expressing metaplasia during Helicobacter heilmannii infection.
    Liu C; Smet A; Blaecher C; Flahou B; Ducatelle R; Linden S; Haesebrouck F
    Infect Immun; 2014 Aug; 82(8):3227-39. PubMed ID: 24866791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma.
    Yang L; Kuang LG; Zheng HC; Li JY; Wu DY; Zhang SM; Xin Y
    World J Gastroenterol; 2003 Jan; 9(1):35-9. PubMed ID: 12508347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis.
    Johnson AH; Frierson HF; Zaika A; Powell SM; Roche J; Crowe S; Moskaluk CA; El-Rifai W
    Am J Pathol; 2005 Aug; 167(2):577-84. PubMed ID: 16049341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel gastrokine, Gkn3, marks gastric atrophy and shows evidence of adaptive gene loss in humans.
    Menheniott TR; Peterson AJ; O'Connor L; Lee KS; Kalantzis A; Kondova I; Bontrop RE; Bell KM; Giraud AS
    Gastroenterology; 2010 May; 138(5):1823-35. PubMed ID: 20138039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.